PolyPid PYPD
NASDAQ PYPD
$5.20 -0.13 (-2.44%)
At close: Sep 9, 2026 · 4:00 PM EDT

PolyPid (PYPD) Non Operating Interest Expenses (2019 - 2021)

PolyPid's (PYPD) quarterly Non Operating Interest Expenses came in at -$152000.0 in Q4 2021, up 55.16% year-over-year from -$97962.0 in Q4 2020, and down 17.83% quarter-over-quarter from -$129000.0 in Q3 2021.

Analysis

PolyPid (PYPD) Non Operating Interest Expenses (2019 - 2021) Analysis & Trends

PolyPid has disclosed Non Operating Interest Expenses across 3 years of filings, most recently posting -$152000.0 for Q4 2021.

  • In Q4 2021, Non Operating Interest Expenses rose 55.16% year-over-year to -$152000.0; the TTM figure through Dec 2021 stood at -$773000.0 (down 108.97% YoY), while the FY2025 annual figure was $1.2 million, down 20.39% from the prior year.
  • Non Operating Interest Expenses came in at -$152000.0 for Q4 2021 at PolyPid, down from -$129000.0 in the prior quarter.
  • In the past five years, Non Operating Interest Expenses ranged from a high of $9.7 million in Q2 2020 to a low of -$5.0 million in Q2 2019.
  • Average Non Operating Interest Expenses over 3 years is $398375.0, with a median of -$185500.0 recorded in 2020.
  • Year-over-year, Non Operating Interest Expenses soared 294.61% in 2020 and sank 101.57% in 2021.
  • Over 3 years, Non Operating Interest Expenses stood at -$548000.0 in 2019, then surged by 38.14% to -$339000.0 in 2020, then surged by 55.16% to -$152000.0 in 2021.
  • Per Business Quant data, the three most recent Non Operating Interest Expenses figures were -$152000.0 in Q4 2021, -$129000.0 in Q3 2021, and -$153000.0 in Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 673.00 Mn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 247.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 11.00 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -1.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 82.05 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 PolyPid 85.52 Mn 78.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -152,000.00
Sep 30, 2021 -129,000.00
Jun 30, 2021 -153,000.00
Dec 31, 2020 -339,000.00
Sep 30, 2020 -218,000.00
Jun 30, 2020 9.72 Mn
Dec 31, 2019 -548,000.00
Jun 30, 2019 -5.00 Mn